Belecodaq,
belinostat,
PXD101,
Belinostat,
414864-00-9,
PXD101,
Belinostat (PXD101),
PXD-101,
Beleodaq,
N-HYDROXY-3-(3-PHENYLSULFAMOYLPHENYL)ACRYLAMIDE,
(E)-N-hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide,
PXD 101,
UNII-F4H96P17NZ,
NSC726630,
PX105684,
PX 105684,
PX-105684,
F4H96P17NZ,
(2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide,
CHEBI:61076,
N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PROPENAMIDE,
(E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]prop-2-enamide,
N-Hydroxy-3-(3-phenylsulphamoylphenyl)acrylamide,
N-Hydroxy-3-(3-(N-phenylsulfamoyl)phenyl)acrylamide,
(2E)-N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]acrylamide,
N-hydroxy-3-(3-(phenylsulfamoyl)phenyl)prop-2-enamide,
(E)-3-[3-(phenylsulfamoyl)phenyl]prop-2-enehydroxamic acid,
E-Belinostat,
2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-, (2E)-,
Belinostat [USAN:INN],
2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-, (2E)-,
Belinostat Ph3,
Beleodaq (TN),
PubChem22405,
Belinostat - PXD101,
AC1OCFO7,
Belinostat (USAN/INN),
Belinostat (PXD101),
MLS006011091,
N-hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide,
CHEMBL408513,
GTPL7496,
BDBM25150,
CHEBI:94531,
DTXSID60194378,
EX-A180,
QCR-181,
NCNRHFGMJRPRSK-MDZDMXLPSA-N,
BCPP000351,
AOB87787,
BCP01741,
ZINC3818726,
Belinostat,PXD101, PX105684,
Belinostat/PXD101,PX105684/,
ABP000140,
MFCD08064035,
s1085,
AKOS025401741,
AN-1073,
API0003555,
BCP9000386,
CCG-208758,
DB05015,
LS41098,
NSC-726630,
RL03602,
SB16466,
NCGC00263155-05,
AC-25046,
AS-17068,
BC251660,
SC-71101,
SMR004702879,
AB0007889,
AX8144528,
RT-014445,
SW219445-1,
EC-000.2286,
A25012,
D08870,
W-5363,
J-523584,
BRD-K17743125-001-01-9,
N-Hydroxy-3-[(phenylamino)sulfonyl]-trans-cinnamamide,
(E)-N-Hydroxy-3-(3-phenylsulfamoyl-phenyl)-acrylamide,
N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]-2-propenamide,
N-HYDROXY-3-[3-[(PHENYLAMINO)SULFONYL]PHENYL]-2-PR,
PX105684, 414864-00-9,
5OG,
Belecodaq,
Belinostat [USAN],
Belinostat(PXD101),
D0XT6W,
cc-489,
PDX101,
Belinostat (Non-Stereospecific),
PDX-101,
ACN-029567,
CID6918638,
866323-14-0,
A4096,
A10122,
C487081,
2-Propenamide, N-hydroxy-3-(3-((phenylamino)sulfonyl)phenyl)-,
2-Propenamide, N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-,
Belinostat, 98%, a new type of HDAC inhibitor - 10MG 10mg,
2-Propenamide,N-hydroxy-3-[3-[(phenylamino)sulfonyl]phenyl]-,(2E)-,